Brakke Consulting’s latest multiclient study takes an in-depth look at pain management products for dogs and cats.
”The pain management market has been one of the fastest growing areas in animal health, with a variety of new active ingredients and novel formulations in the past 20 years,” said Lynn Fondon DVM MBA, senior consultant of Brakke Consulting. “Sales of small animal analgesics have increased 20-fold since the introduction of Rimadyl, the first of the new-generation NSAIDs, in 1996.”
The study, Pain Management Products for Dogs and Cats, profiles the veterinary market for analgesics, both veterinary and human products, as well as nutritional supplements and therapeutic diets for joint support. The report includes an overview of pain management in veterinary medicine, leading product sales and pricing, and a discussion of new and developing products, including a number of novel molecules. The report also includes a survey of small animal veterinarians.
“Our veterinary survey found that veterinarians are largely satisfied with the available products for dogs, but feel there is a need for safer analgesics for cats, particularly those that can be used long-term,” comments Dr. Fondon.
The report – published annually by Brakke for the past decade – gathered information from a variety of sources, including published information, industry interviews and a survey of over 300 small animal veterinarians.
The 2016 Pain Management Products for Dogs and Cats report is available from Brakke Consulting for $5,995. For more information, interested companies should contact firstname.lastname@example.org.
About Brakke Consulting
For 30 years, Brakke Consulting has offered comprehensive solutions for the animal health industry, including market research, new business development, product evaluation, and distribution strategies. The company is known for its syndicated market studies, providing strategic, timely information for the industry. Learn more about the company at www.BrakkeConsulting.com